Hebei Jianxin Chemical (SZSE:300107) Investors Are up 8.0% in the Past Week, but Earnings Have Declined Over the Last Year
Hebei Jianxin Chemical (SZSE:300107) Investors Are up 8.0% in the Past Week, but Earnings Have Declined Over the Last Year
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you pick the right stock, you can make a lot more than 100%. Take, for example Hebei Jianxin Chemical Co., Ltd. (SZSE:300107). Its share price is already up an impressive 143% in the last twelve months. On top of that, the share price is up 31% in about a quarter. But this move may well have been assisted by the reasonably buoyant market (up 21% in 90 days). It is also impressive that the stock is up 129% over three years, adding to the sense that it is a real winner.
您在任何一支股票上最多可能虧損的金額(假設您不使用槓桿)是您的全部資金的100%。但如果您選擇了正確的股票,您可以賺取的金額遠遠超過100%。舉個例子,建新股份化工股份有限公司(SZSE:300107)。其股價在過去十二個月中已經上漲了令人印象深刻的143%。除此之外,股價在大約一個季度內上漲了31%。但這一舉動很可能得到了相對旺盛的市場的幫助(90天漲幅達21%)。股價在三年內上漲了129%,這也令人印象深刻,進一步增強了其真正贏家的感覺。
Since it's been a strong week for Hebei Jianxin Chemical shareholders, let's have a look at trend of the longer term fundamentals.
由於這對建新股份股東來說是一個強勁的一週,讓我們來看看長期基本面趨勢。
We don't think that Hebei Jianxin Chemical's modest trailing twelve month profit has the market's full attention at the moment. We think revenue is probably a better guide. Generally speaking, we'd consider a stock like this alongside loss-making companies, simply because the quantum of the profit is so low. It would be hard to believe in a more profitable future without growing revenues.
我們認爲建新股份化工股份有限公司不起眼的過去十二個月利潤可能目前未引起市場的充分關注。我們認爲營業收入可能是一個更好的指導。一般而言,我們會將這樣的股票與虧損公司同時考慮,僅僅因爲利潤數量如此之低。很難在沒有營收增長的情況下相信更加盈利的未來。
Hebei Jianxin Chemical actually shrunk its revenue over the last year, with a reduction of 2.8%. We're a little surprised to see the share price pop 143% in the last year. This is a good example of how buyers can push up prices even before the fundamental metrics show much growth. It's quite likely the revenue fall was already priced in, anyway.
建新股份化工股份有限公司實際上在過去一年裏減少了2.8%的營業收入。看到股價在過去一年中上漲了143%,我們感到有點驚訝。這是一個很好的例子,說明買家可以在基本指標顯示出明顯增長之前推高價格。營收下降很可能已經在股價中反映,無論如何。
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
下面的圖表顯示了收益和營收隨時間的變化情況(通過單擊圖像揭示確切的值)。
It's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. This free interactive report on Hebei Jianxin Chemical's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.
值得注意的是,CEO的薪酬比類似規模的公司中位數要低。但雖然CEO的報酬值得關注,真正重要的問題是公司未來能否增長收入。如果您想進一步調查這隻股票,建新股份的收入、營業收入和現金流情況的這份免費互動報告是個絕佳的起點。
A Different Perspective
另一種看法
We're pleased to report that Hebei Jianxin Chemical shareholders have received a total shareholder return of 144% over one year. That's including the dividend. That gain is better than the annual TSR over five years, which is 17%. Therefore it seems like sentiment around the company has been positive lately. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 2 warning signs for Hebei Jianxin Chemical you should be aware of.
我們很高興地報告,建新股份的股東在一年內獲得了總股東回報率爲144%。這已包括了股息。這一收益比過去五年每年的TSR 17%要好。因此,最近圍繞該公司的情緒似乎是積極的。在最理想的情況下,這可能暗示着一些真實的業務動力,這可能意味着現在是深入了解的好時機。雖然值得考慮市場條件對股價的影響,但有一些更重要的因素。例如,我們發現了建新股份的2個警示信號,您應該注意。
Of course Hebei Jianxin Chemical may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
當然,建新股份可能不是最好的股票買入選擇。因此,您可能希望查看這些免費的成長股股票收藏。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文中引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。